Efficiencies of platform clinical trials: A vision of the futureBenjamin R. Saville, Scott Berry|Clinical Trials|2016Cited by 318
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialLy‐Mee Yu, Christina Saunders, Mark Fitzgerald et al.|The Lancet|2021Cited by 310
The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trialsBenjamin R. Saville, Scott Berry, Donald A. Berry et al.|Clinical Trials|2022Cited by 72
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trialChristopher Butler, Ly‐Mee Yu, Mona Bafadhel et al.|medRxiv|2021Cited by 28
Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic FibrosisAndré Schultz, Tom Snelling, Julie Marsh et al.|Frontiers in Pharmacology|2019Cited by 11